Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Amplia Therapuetics Limited
Amplia Therapeutics Announces Opening of US Sites for Amplicity Pancreatic Cancer Trial
February 11, 2026
From
Amplia Therapuetics Limited
Via
GlobeNewswire
Tickers
ASX:ATX
INNMF
Amplia Therapeutics - Quarterly Activities and Cash Flow Reports - December 2025
January 30, 2026
From
Amplia Therapuetics Limited
Via
GlobeNewswire
Tickers
ASX:ATX
INNMF
NARMAFOTINIB Large-Scale Manufactre Complete
January 22, 2026
From
Amplia Therapuetics Limited
Via
GlobeNewswire
Tickers
ASX:ATX
INNMF
ACCENT DATA PRESENTED AT 2026 ASCO GASTROINTESTINAL CANCER SYMPOSIUM
January 12, 2026
From
Amplia Therapuetics Limited
Via
GlobeNewswire
Tickers
ASX:ATX
INNMF
Amplia Therapeutics to Present at 2026 ASCO Gastrointestinal Cancers Symposium
December 23, 2025
From
Amplia Therapuetics Limited
Via
GlobeNewswire
Tickers
ASX:ATX
INNMF
Amplia Enters into Second Agreement with Korean Specialist Drug Screening Company Next&Bio to Explore Combination Therapy with FAK Inhibitor and kRAS Inhibitors
December 19, 2025
From
Amplia Therapuetics Limited
Via
GlobeNewswire
Tickers
ASX:ATX
INNMF
Additional Confirmed Response Reported as Part of Amplia Investor Presentation
December 12, 2025
From
Amplia Therapuetics Limited
Via
GlobeNewswire
Tickers
ASX:ATX
INNMF
Key Narmafotinib Patent Granted in the U.S.
December 03, 2025
From
Amplia Therapuetics Limited
Via
GlobeNewswire
Tickers
ASX:ATX
INNMF
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.